Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2016

01-01-2016 | Original Article

A team-based multidisciplinary approach to managing peripherally inserted central catheter complications in high-risk haematological patients: a prospective study

Authors: Natalia Curto-García, Julio García-Suárez, Marta Callejas Chavarria, Juan José Gil Fernández, Yolanda Martín Guerrero, Elena Magro Mazo, Shelly Marcellini Antonio, Luis Miguel Juárez, Isabel Gutierrez, Juan José Arranz, Irene Montalvo, Carmen Elvira, Pilar Domínguez, María Teresa Díaz, Carmen Burgaleta

Published in: Supportive Care in Cancer | Issue 1/2016

Login to get access

Abstract

Purpose

Use of peripherally inserted central catheters (PICCs) has markedly increased during the last decade. However, there are few studies on use of PICCs in patients with haematological malignancies (HM) receiving intensive chemotherapy. Preliminary data suggest a higher rate of PICC-related complications in these high-risk patients. This prospective observational single-centre study aimed to investigate PICC-related complications after implementation of a multidisciplinary approach to PICC care and compared it with previous literature.

Methods

A total of 44 PICCs were inserted in 36 patients (27.3 %, thrombocytopenia <50 × 109/L at insertion) over 5045 PICC days (median duration, 114.5 days).

Results

No major insertion-related complications were observed. Major late complications were obstruction in 13.6 % (1.19/1000 PICC days) of patients, catheter-related bloodstream infection in 6.8 % (0.59/1000 PICC days), and catheter-related thrombosis in 4.5 % (0.39/1000 PICC days). Premature PICC removal occurred in 34 % (2.97/1000 PICC days) of patients. The overall rate of potentially major dangerous complications was particularly low (11.36 %, 0.99/1000 PICC days) compared with previous studies.

Conclusions

This study highlights the utility of a multidisciplinary approach for PICC care in adults with HM receiving intensive chemotherapy. We provide further data to support use of PICCs in such patient populations.
Appendix
Available only for authorised users
Literature
1.
Johansson E, Björkholm M, Björvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia—a randomized study. Support Care Cancer 12(2):99–105CrossRefPubMed
2.
Worth LJ, Seymour JF, Slavin MA (2009) Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices. Support Care Cancer 17:811–818CrossRefPubMed
3.
Harter C, Ostendorf T, Bach A, Egerer G, Goldschmidt H, Ho AD (2003) Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies. Support Care Cancer 11:790–794CrossRefPubMed
4.
Gastmeier P, Geffers C (2006) Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 64(4):326–335CrossRefPubMed
5.
Walshe LJ, Malak SF, Eagan J, Sepkowitz KA (2002) Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 20:3276–3281CrossRefPubMed
6.
Chopra V, Anand S, Hickner A, Buist M, Rogers AM, Saint S, Flanders SA (2013) Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 382(9889):311–325CrossRefPubMed
7.
Skaff ER, Doucette S, McDiarmid S, Huebsch L, Sabloff M (2012) Vascular access devices in leukemia: a retrospective review amongst patients treated at The Ottawa Hospital with induction chemotherapy for acute leukemia. Leukemia Lymphoma 53(6):1090–1095CrossRefPubMed
8.
Aw A, Carrier a M, Koczerginski J, McDiarmid S, Tay J (2012) Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res 130:323–326CrossRefPubMed
9.
Bellesi S, Chiusolo P, De Pascale G, Pittiruti M, Scoppettuolo G, Metafuni E, Giammarco S, Sorà F, Laurenti L, Leone G, Sica S (2012) Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation. Support Care Cancer. doi:10.​1007/​s00520-012-1554-0 PubMed
10.
Tran H, Arellano M, Chamsuddin A, Flowers C, Heffner LT, Langston A, Lechowicz MJ, Tindol A, Waller E, Winton EF, Khoury HJ (2010) Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leukaemia Lymphoma 51(8):1473–1477CrossRef
11.
McDiarmid S, Hamelin L, Huebsch LB (2006) Retrospective evaluation of a nurse-led initiative in vascular access options for autologous stem cell transplant recipients ranging from Hickman catheters to peripherally inserted central catheters. J Infus Nurs 29(2):81–88CrossRefPubMed
12.
Strahilevitz J, Lossos IS, Verstandig A, Sasson T, Kori Y, Gillis S (2001) Vascular access via peripherally inserted central venous catheters (PICCs): experience in 40 patients with acute myeloid leukemia at a single institute. Leukaemia Lymphoma 40(3–41):365–371CrossRef
13.
Leonard AM, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis 49(1):1–45. doi:10.​1086/​599376 CrossRef
14.
O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee (HICPAC) (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162–e193PubMedCentralCrossRefPubMed
15.
O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 30(8):476–489CrossRefPubMed
16.
Lamperti M, Bodenham AR, Pittiruti M, Blaivas M, Augoustides JG, Elbarbary M, Pirotte T, Karakitsos D, Ledonne J, Doniger S, Scoppettuolo G, Feller-Kopman D, Schummer W, Biffi R, Desruennes E, Melniker LA, Verghese ST (2012) International evidence-based recommendations on ultrasound-guided vascular access. Intensive Care Med 38(7):1105–1117. doi:10.​1007/​s00134-012-2597-x, Epub 2012 May 22CrossRefPubMed
17.
Infusion nursing standards of practice developed by Infusion Nurses Society (2011) Infusion Nurses Society; 34:S1–S109. Available from: http: //www.​ins1.​org
18.
Vesely TM (2003) Central venous catheter tip position: a continuing controversy. J Vasc Interv Radiol 14:527–534CrossRefPubMed
19.
Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P (2005) Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 13(5):325–331CrossRefPubMed
20.
Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK (2013) Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leukemia Lymphoma 54(6):1263–1267CrossRefPubMed
21.
Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmüller R, Kühr T, Wimmer L, Thaler J (2010) Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care (Engl) 19(5):676–681CrossRef
22.
Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, McDougall C, Wilcox MH (2007) EPIC2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65(Suppl 1):S1–S64CrossRefPubMed
23.
Penel N, Neu JC, Clisant S, Hoppe H, Devos P, Source YY (2007) Risk factors for early catheter-related infections in cancer patients. Cancer 110(7):1586–1592CrossRefPubMed
24.
Chaberny IF, Ruseva E, Sohr D, Buchholz S, Ganser A, Mattner F, Gastmeier P (2009) Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol 88(9):907–912CrossRefPubMed
25.
Allen AW, Megargell JL, Brown DB, Lynch FC, Singh H, Singh Y, Waybill PN (2000) Venous thrombosis associated with the placement of peripherally inserted central catheter. J Vasc Int Radiol 11(10):1309–1314CrossRef
26.
Meyer BM (2012) Developing an alternative workflow model for peripherally inserted central catheter placement. J Infusion Nurs 35(1):34–42CrossRef
27.
Dix CHK, Yeung DTO, Rule ML, Ma DDF (2012) Essential, but at what risk? A prospective study on central venous access in patients with haematological malignancies. Intern Med J 42(8):901–906CrossRefPubMed
28.
Ohno H, Mizumoto C, Otsuki Y, Oguma S, Yoshida Y (2010) The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumours: a single institution-based study. Int J Clin Oncol 15(2):172–178CrossRefPubMed
Metadata
Title
A team-based multidisciplinary approach to managing peripherally inserted central catheter complications in high-risk haematological patients: a prospective study
Authors
Natalia Curto-García
Julio García-Suárez
Marta Callejas Chavarria
Juan José Gil Fernández
Yolanda Martín Guerrero
Elena Magro Mazo
Shelly Marcellini Antonio
Luis Miguel Juárez
Isabel Gutierrez
Juan José Arranz
Irene Montalvo
Carmen Elvira
Pilar Domínguez
María Teresa Díaz
Carmen Burgaleta
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2754-1

Other articles of this Issue 1/2016

Supportive Care in Cancer 1/2016 Go to the issue

Original Article

An interdisciplinary palliative rehabilitation intervention bolstering general self-efficacy to attenuate symptoms of depression in patients living with advanced cancer

Original Article

Interval versus continuous aerobic exercise training in breast cancer survivors—a pilot RCT

Original Article

The need and availability of dental services for terminally ill cancer patients: a nationwide survey in Japan

Original Article

Developing a clinical pathway for the identification and management of anxiety and depression in adult cancer patients: an online Delphi consensus process

Original Article

Risk of thiamine deficiency and Wernicke’s encephalopathy after gastrointestinal surgery for cancer

Original Article

Addressing psychosocial needs of partners of breast cancer patients: a pilot program using social workers to improve communication and psychosocial support
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits